DOGE-ing US FDA: Three Scenarios For What Comes Next

 
• By Michael McCaughan and Ramsey Baghdadi
  
One scenario for FDA restructuring could be combining the drug and biologics centers. (Shutterstock)

More from US FDA

More from Pathways & Standards